We care about rare disease patients
Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the health of rare disease patients and their families. The portfolio comprises about 60 marketed products, as well as projects in late clinical phase. Key therapeutic areas are hematological diseases, autoimmune diseases, hereditary metabolic disorders and therapeutic oncology.
We have a pan-European commercial organization, an emerging organization in North America, and partners in and the Middle East, Australia and New Zealand. Sobi has a strong business development track-record and compelling product development and manufacturing capabilities.
The organization possesses a high level of expertise and resources within all areas of the value chain, from pre-clinical research and development, business development and production to market access, marketing, distribution and customer support. We are about 500 employees.